New Steroid Alert $ATVK - Ameritek Ventures Inc ATVK -

New Post Public Reply Private Reply Replies (0) Message Board
Compensated Post
PhotoChick
411
New Steroid Alert $ATVK - Ameritek Ventures Inc

ATVK - Ameritek Ventures Inc.

According to Ameritek Ventures website

Website: https://www.ameritekventures.com/

ABOUT AMERITEK VENTURES

Ameritek Ventures is a manufacturer of proprietary machinery that is used to produce optical fiber preforms. These preforms are then used to produce commercial grade optical fiber. Once produced, this optical fiber is fabricated into fiber optic cable which serves as the backbone of the multi-billion dollar telecommunication industry.

The market demand for preforms and optical fiber has experienced rapid growth in the wireless, cable television, internet and high-speed data transmission industries. The Company's equipment, processes and managed system deployments will provide the market with the highest quality preforms used to manufacture fiber optic cable and will support significant growth worldwide.

Ameritek Ventures, Inc. (ATVK) will use their own proprietary technology in the manufacturing of optical fiber preforms. They will then provide preforms to the market to then be used in the manufacture of optical fiber and finished optical fiber cable.

Ameritek’s products will support the continued growth of communication networks throughout the world. Broadband, Cable Television and High Speed Internet providers will benefit from the world-class quality, excellent customer service and superior value as they expand their networks and bring information to more people globally.

They believe in the strength and ingenuity of the American manufacturing market and the people that are dedicated to bring the best of new technologies to the marketplace, right here in the place where the manufacturing industry was born.


Products

SINGLE MODE OPTICAL FIBER PREFORMS

PRODUCT DESCRIPTION

AMERITEK offers optical fiber preforms that can be drawn into G.652 optical fiber.

AMERITEK’s preforms are made to optimize the draw process time, maximize fiber yield and minimize fiber/cable cost. We offer standard sizes, configurations and can also configure our preforms to meet your existing draw conditions.

AMERITEK offers a different variety of G.652 type optical fiber which supports applications such as long haul, rural-metro-city access, cell phone and cable television networks. The use of advanced raw materials, robust design and state-of-the-art manufacturing processes make these products compatible with existing networks as well as suitable for state of the art network configurations.

SPECS

Model: Dispersion unshifted single-mode optical fiber (G.652)

Standard: IEC 60793-2-50:2008 Product Specifications-Part2-50, ITU-T Recommendation G.652:2008 Characteristics of a Single-Mode Optical Fiber and Cable, and GB/T 9771.1-2008 Communication Single-mode Optical Fiber Series Part 1: Characteristics of Dispersion Unshifted Single Mode Optical Fiber.

FEATURES

High Strength

Low Attenuation

Long Service Life

APPLICATION

To be drawn into fiber meeting G.652 single-mode optical fiber. Used in high bandwidth and long-distance transmission networks. This is the most widely used type of fiber and suitable for most communication networks.

TYPES OF OPTICAL FIBER CABLE

Cable for Aerial Applications

Direct Buried Cable

Cable for Duct Applications

Optical Fiber Ribbon Cable


Security Details

http://www.otcmarkets.com/stock/ATVK/company-info


News Disclaimer
(Press Releases have not been investigated by PennyStocks on Steroids, therefore, we have no idea if the content of this news is based on Fact or Fiction. Although the link for the following press release may be from a familiar and reputable news source, you should NOT assume that a press wire hosted by a website you are familiar with is accurate just because it is on their site. PennyStocks on Steroids will not be held responsible for any news release, including and not limited to misleading or non-factual content, or the accuracy of the identity of the given source of the press release.)

April 25, 2018 - KCSA Strategic Communications
Ameritek Ventures Signs Definitive Term Sheet for $16 Million Private Debenture Financing - Net Proceeds to Provide Working Capital to Drive Manufacturing and Production Plan Execution
https://www.ameritekventures.com/single-post/...-Execution

April 17, 2018 - KCSA Strategic Communications
Ameritek Ventures Secures Access To More Than $1 Million in Funding Towards Executing Its Strategic Business Plan
https://www.ameritekventures.com/single-post/...iness-Plan

March 8, 2018 - KCSA Strategic Communication

Ameritek Ventures Projects Supply of Optical Fiber to Remain Insufficient to Meet Robust Network Demand - Company Advancing Towards Production of Optical Fiber Preforms
https://www.ameritekventures.com/single-post/...r-Preforms

March 5, 2018 - KCSA Strategic Communications

Ameritek Ventures’ Presentation Now Available for On-Demand Viewing
https://www.ameritekventures.com/single-post/...nd-Viewing

February 22, 2018 - Ameritek Ventures
Ameritek Ventures Announces Concept Design Work Has Been Completed for Production of Optical Fiber Preforms at Roanoke, Virginia Manufacturing Facility
https://www.ameritekventures.com/single-post/...g-Facility



Contact


AMERITEK VENTURES

1980 Festival Plaza Drive #530
Las Vegas, NV 89135
Ph. 877-571-1776
Fax: 941-803-0872
info@ameritekventures.com

KCSA Strategic Communications

420 Fifth Avenue 3rd Floor
New York, NY 10018
Phil Carlson Ph. 212-896-1233
Steve Silver Ph. 212-896-1220



This Alert brought to you by Penny Stocks on Steroids



Contact Us:
admin@pennystocksonsteroids.com

Get Super FAST Text Alerts to Your Phone!

Text "Posstocks" to 31279


Follow Us on Twitter
http://www.twitter.com/POSstocks


Follow Us on Facebook
http://www.facebook.com/pos.stocks


Follow us at PennyStockTweets
http://www.pennystocktweets.com/profile/POSstocks

Penny Stocks are very volatile and with investing in any security there is always risk. Always Educate yourself and do your own Due Diligence before investing in ANY Security.


Read More: https://investorshangout.com/post/view?id=503...z5F0kWWsSr
Scroll down for more posts ▼

Top 10 Most Recent News Articles

LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 170

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 108

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 358

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 336

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 364

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 86

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 372

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 64

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading

Top 5 Most Recently Viewed Articles

Analyzing Trump's Executive Orders and Their Economic Impact

Updated Category News Views 806

Executive Orders: A Shift in Economic Paradigms President Trump has taken significant steps by issuing a number of executive orders that have raised eyebrows among economists and market analysts alike. According to market expert Louis Navellier, this approach can be characterized as 'shock and awe'. It reflects a bold strategy that could reshape various aspects of the...

Continue Reading
B2PRIME Expands Institutional Reach with Stuart Brock's Addition

Updated Category News Views 173

B2PRIME Welcomes Stuart Brock as Institutional Business Development Manager B2PRIME Group, a leading financial services provider for institutional and professional clients, recently announced the appointment of Stuart Brock as its Institutional Business Development Manager. With over 15 years of experience in electronic trading and institutional sales, Stuart is poised to...

Continue Reading
United Parks & Resorts Inc. Shares Q1 2025 Financial Insights

Updated Category News Views 374

Financial Overview of United Parks & Resorts Inc. United Parks & Resorts Inc. (NYSE: PRKS), a prominent player in the theme park and entertainment sector, has recently shared its financial results for the first quarter of 2025. This report delves into the key metrics and operational insights that define the company’s performance in this period. Attendance and Revenue...

Continue Reading
Seongnam Pavilion Sets New Benchmark at CES 2025 with 41 Companies

Updated Category News Views 178

Seongnam Pavilion Makes Waves at CES 2025 At the latest CES 2025, Seongnam City showcased an impressive turnout at the world's leading consumer electronics exhibition. This year, Seongnam participated with a remarkable delegation of 41 companies, marking the largest participation ever. Focused on enhancing their global footprint, these small and medium-sized enterprises...

Continue Reading
Gaucho Holdings Seizes Opportunities Amid Argentina's Economic Revival

Updated Category News Views 179

Gaucho Holdings and the New Economic Landscape in Argentina Recently, Argentina has entered a new chapter of economic transformation. A shift in leadership, with Javier Milei becoming president, has sparked hopes for fiscal discipline, growth, and development. As the country embraces pro-market reforms, Gaucho Group Holdings, Inc. (NASDAQ: VINO) positions itself to...

Continue Reading